In particular, the 3rd booster shot of COVID-19 vaccine demonstrated a more effective and sustained promoting effect on EOS, while inhibiting the CRP level, both in the asymptomatic and mild patients (Fig. 3). This evidence concerns the gene CRP and COVID-19.